Gutiérrez-Aguilar Manuel, Baines Christopher P
Dalton Cardiovascular Research Center, University of Missouri-Columbia, Columbia, MO 65211, USA.
Dalton Cardiovascular Research Center, University of Missouri-Columbia, Columbia, MO 65211, USA; Department of Biomedical Sciences, University of Missouri-Columbia, Columbia, MO 65211, USA; Department of Medical Pharmacology and Physiology, University of Missouri-Columbia, Columbia, MO 65211, USA.
Biochim Biophys Acta. 2015 Oct;1850(10):2041-7. doi: 10.1016/j.bbagen.2014.11.009. Epub 2014 Nov 13.
Opening of the mitochondrial permeability transition pore is the underlying cause of cellular dysfunction during diverse pathological situations. Although this bioenergetic entity has been studied extensively, its molecular componentry is constantly debated. Cyclophilin D is the only universally accepted modulator of this channel and its selective ligands have been proposed as therapeutic agents with the potential to regulate pore opening during disease.
This review aims to recapitulate known molecular determinants necessary for Cyclophilin D activity regulation and binding to proposed pore constituents thereby regulating the mitochondrial permeability transition pore.
While the main target of Cyclophilin D is still a matter of further research, permeability transition is finely regulated by post-translational modifications of this isomerase and its catalytic activity facilitates pore opening.
Complete elucidation of the molecular determinants required for Cyclophilin D-mediated control of the mitochondrial permeability transition pore will allow the rational design of therapies aiming to control disease phenotypes associated with the occurrence of this unselective channel. This article is part of a Special Issue entitled Proline-directed Foldases: Cell Signaling Catalysts and Drug Targets.
线粒体通透性转换孔的开放是多种病理情况下细胞功能障碍的根本原因。尽管对这一生物能量学实体已进行了广泛研究,但其分子组成仍存在争议。亲环蛋白D是该通道唯一被普遍认可的调节因子,其选择性配体已被提议作为治疗药物,有可能在疾病期间调节孔的开放。
本综述旨在概括亲环蛋白D活性调节以及与假定的孔成分结合从而调节线粒体通透性转换孔所需的已知分子决定因素。
虽然亲环蛋白D的主要靶点仍有待进一步研究,但通透性转换由该异构酶的翻译后修饰精细调节,其催化活性促进孔的开放。
全面阐明亲环蛋白D介导的线粒体通透性转换孔调控所需的分子决定因素,将有助于合理设计旨在控制与这种非选择性通道出现相关疾病表型的疗法。本文是名为“脯氨酸定向折叠酶:细胞信号催化剂和药物靶点”的特刊的一部分。